The Food and Drug Administration May 27 authorized the emergency use of the Stryker Sustainability Solutions VHP N95 Respirator Decontamination System during the COVID-19 pandemic.

The device decontaminates compatible N95 respirators for multiple-user reuse to prevent exposure to pathogenic biological airborne particulates when there are insufficient supplies of face-filtering respirators. Hospitals should note that N95 respirators containing cellulose-based materials are incompatible with the SSS VHP N95 RDS and respirators are limited to a maximum of three decontaminations via the device.

Related News Articles

Headline
In a study of more than 4,900 health care workers across 33 sites in 25 U.S. states, the Pfizer and Moderna COVID-19 vaccines were 89% and 96% effective,…
Headline
The AHA today released the latest edition of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the…
Headline
The Food and Drug Administration today required certain COVID-19 test developers to evaluate how SARS-CoV-2 mutations impact their test’s performance and…
Headline
The Food and Drug Administration late last night amended Pfizer’s emergency use authorization for its COVID-19 vaccine to allow for an additional, booster…
Headline
In AHA’s newest #MyWhy video, nine hospital employees from UAB Medicine in Alabama candidly discuss their COVID-19 vaccine experience, starting with initial…
Headline
The Centers for Medicare & Medicaid Services yesterday began publicly sharing COVID-19 vaccination rates for nursing home staff and residents on its Care…